HomeClinics HomeAbout ClinicsAll ClinicsHot TopicsAdvancesSpecial OffersCME
Logo
Search for

Volume 16, Issue 3, Pages 607-625 (July 2007)


View previous. 12 of 19 View next.

The Role of Minimal Access Surgery for Metastasectomy and Cytoreduction

Horacio J. Asbun, MDabCorresponding Author Informationemail address, Michaela Straznicka, MDc, Vivian E. Strong, MDd

This article summarizes findings about the applicability of minimal-access techniques for thoracic and upper gastrointestinal cancers, including those affecting the lung, liver, stomach, and adrenal gland. If metastasectomy and cytoreductive surgery are rapidly evolving, minimal-access surgery in this setting is in its introductory stages. Nevertheless, minimal-access metastasectomy and cytoreductive surgery harbor great potential for selected patients, but further clinical studies are needed.

a John Muir Health, 401 Gregory Lane, # 204, Walnut Creek, CA 94523, USA

b Hepatobiliary and Pancreas Cancer Program, John Muir Cancer Institute, 1601 Ygnacio Valley Road, Walnut Creek, CA 94598, USA

c Thoracic Oncology Program, John Muir Cancer Institute, 1601 Ygnacio Valley Road, Walnut Creek, CA 94598, USA

d Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, 1275 York Ave. # 1217, New York, NY 10021, USA

Corresponding Author InformationCorresponding author.

PII: S1055-3207(07)00037-3

doi:10.1016/j.soc.2007.04.008


View previous. 12 of 19 View next.